180 related articles for article (PubMed ID: 34894814)
21. High Grade Transformation in Mucoepidermoid Carcinoma of the Minor Salivary Gland with Polyploidy of the Rearranged MAML2 Gene.
Lee H; Roh JL; Choi YJ; Choi J; Cho KJ
Head Neck Pathol; 2020 Sep; 14(3):822-827. PubMed ID: 31535311
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic utility of Mastermind-like 2 (MAML2) gene rearrangement detection by fluorescent in situ hybridization (FISH) in mucoepidermoid carcinoma of the salivary glands.
Luk PP; Wykes J; Selinger CI; Ekmejian R; Tay J; Gao K; Eviston TJ; Lum T; O'Toole SA; Clark JR; Gupta R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 May; 121(5):530-41. PubMed ID: 27068311
[TBL] [Abstract][Full Text] [Related]
23. HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status.
Nakano T; Yamamoto H; Hashimoto K; Tamiya S; Shiratsuchi H; Nakashima T; Nishiyama K; Higaki Y; Komune S; Oda Y
Histopathology; 2013 Sep; 63(3):378-92. PubMed ID: 23855785
[TBL] [Abstract][Full Text] [Related]
24. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells.
Chen Z; Lin S; Li JL; Ni W; Guo R; Lu J; Kaye FJ; Wu L
Oncogene; 2018 Apr; 37(14):1885-1895. PubMed ID: 29353885
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
[TBL] [Abstract][Full Text] [Related]
26. Mucoepidermoid carcinoma: a five-decade journey.
Chenevert J; Barnes LE; Chiosea SI
Virchows Arch; 2011 Feb; 458(2):133-40. PubMed ID: 21243374
[TBL] [Abstract][Full Text] [Related]
27. Non-sebaceous lymphadenoma-like mucoepidermoid carcinoma: A case report.
Sakamoto S; Miyauchi M; Ando T; Fujihara M; Nakaguro M; Nagao T; Ogawa I
Pathol Int; 2022 Jul; 72(7):371-375. PubMed ID: 35596702
[TBL] [Abstract][Full Text] [Related]
28. Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis.
Cipriani NA; Lusardi JJ; McElherne J; Pearson AT; Olivas AD; Fitzpatrick C; Lingen MW; Blair EA
Am J Surg Pathol; 2019 Jul; 43(7):885-897. PubMed ID: 31021855
[TBL] [Abstract][Full Text] [Related]
29. Mucoepidermoid carcinoma of the head and neck: CRTC1/3 MAML 2 translocation and its prognosticators.
van Weert S; Lissenberg-Witte BI; Bloemena E; Leemans CR
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2573-2581. PubMed ID: 34405264
[TBL] [Abstract][Full Text] [Related]
30. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
[TBL] [Abstract][Full Text] [Related]
31. Pathologic grading of mucoepidermoid carcinomas of the salivary gland and its effect on clinicopathologic follow-up: an institutional experience.
Shafique K; Zhang PJ; Montone KT; Song S; Livolsi VA; Baloch Z
Hum Pathol; 2020 Apr; 98():89-97. PubMed ID: 32035991
[TBL] [Abstract][Full Text] [Related]
32. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.
Lennerz JK; Perry A; Dehner LP; Pfeifer JD; Lind AC
Br J Dermatol; 2009 Oct; 161(4):925-9. PubMed ID: 19438452
[TBL] [Abstract][Full Text] [Related]
33. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
[TBL] [Abstract][Full Text] [Related]
34. MAML2 rearrangement in primary pulmonary mucoepidermoid carcinoma and the correlation with FLT1 expression.
Zhu F; Wang W; Hou Y; Shi J; Liu Z; He D; Bai C; Li S; Jiang L
PLoS One; 2014; 9(4):e94399. PubMed ID: 24714697
[TBL] [Abstract][Full Text] [Related]
35. Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus.
Roden AC; Erickson-Johnson MR; Yi ES; García JJ
Hum Pathol; 2013 Dec; 44(12):2799-805. PubMed ID: 24134933
[TBL] [Abstract][Full Text] [Related]
36. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
[TBL] [Abstract][Full Text] [Related]
37. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions.
Anzick SL; Chen WD; Park Y; Meltzer P; Bell D; El-Naggar AK; Kaye FJ
Genes Chromosomes Cancer; 2010 Jan; 49(1):59-69. PubMed ID: 19827123
[TBL] [Abstract][Full Text] [Related]
38. CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast.
Bean GR; Krings G; Otis CN; Solomon DA; García JJ; van Zante A; Camelo-Piragua S; van Ziffle J; Chen YY
Histopathology; 2019 Feb; 74(3):463-473. PubMed ID: 30380176
[TBL] [Abstract][Full Text] [Related]
39. Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.
Birkeland AC; Foltin SK; Michmerhuizen NL; Hoesli RC; Rosko AJ; Byrd S; Yanik M; Nor JE; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
Oral Oncol; 2017 May; 68():5-8. PubMed ID: 28438292
[TBL] [Abstract][Full Text] [Related]
40. CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland.
Von Holstein SL; Fehr A; Heegaard S; Therkildsen MH; Stenman G
Oncol Rep; 2012 May; 27(5):1413-6. PubMed ID: 22323114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
